Neoantigen-reactive T cells exhibit effective anti-tumor activity against colorectal cancer

References

• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin. 2016;66(1):7–30. doi:10.3322/caac.21332.
   PubMed Web of Science ®Google Scholar
• Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, Jemal A, Yu XQ, He J. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66(2):115–32. doi:10.3322/caac.21338.
   PubMed Web of Science ®Google Scholar
• Biondi A, Vacante M, Ambrosino I, Cristaldi E, Pietrapertosa G, Basile F. Role of surgery for colorectal cancer in the elderly. World J Gastrointest Surg. 2016;8(9):606–13. doi:10.4240/wjgs.v8.i9.606.
   PubMed Web of Science ®Google Scholar
• Biondi A, Grosso G, Mistretta A, Marventano S, Toscano C, Drago F, Gangi S, Basile F. Laparoscopic vs. open approach for colorectal cancer: evolution over time of minimal invasive surgery. BMC Surg. 2013;13 Suppl 2(Suppl2):S12. doi:10.1186/1471-2482-13-s2-s12.
   PubMedGoogle Scholar
• Van Loon K, Venook AP. Curable patient with metastatic colorectal cancer: balancing effective therapies and toxicities. J Clin Oncol. 2014;32(10):991–96. doi:10.1200/jco.2013.53.5195.
   PubMed Web of Science ®Google Scholar
• Sharif S, O’Connell MJ, Yothers G, Lopa S, Wolmark N. FOLFOX and FLOX regimens for the adjuvant treatment of resected stage II and III colon cancer. Cancer Invest. 2008;26(9):956–63. doi:10.1080/07357900802132550.
   PubMed Web of Science ®Google Scholar
• Pardoll D, Allison J. Cancer immunotherapy: breaking the barriers to harvest the crop. Nat Med. 2004;10(9):887–92. doi:10.1038/nm0904-887.
   PubMed Web of Science ®Google Scholar
• Lesterhuis WJ, Haanen JB, Punt CJ. Cancer immunotherapy–revisited. Nat Rev Drug Discov. 2011;10(8):591–600. doi:10.1038/nrd3500.
   PubMed Web of Science ®Google Scholar
• Llosa NJ, Cruise M, Tam A, Wicks EC, Hechenbleikner EM, Taube JM, Blosser RL, Fan H, Wang H, Luber BS, et al. The vigorous immune microenvironment of microsatellite instable colon cancer is balanced by multiple counter-inhibitory checkpoints. Cancer Discov. 2015;5(1):43–51. doi:10.1158/2159-8290.cd-14-0863.
   PubMed Web of Science ®Google Scholar
• Keskin DB, Anandappa AJ, Sun J, Tirosh I, Mathewson ND, Li S, Oliveira G, Giobbie-Hurder A, Felt K, Gjini E, et al. Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial. Nature. 2019;565(7738):234–39. doi:10.1038/s41586-018-0792-9.
   PubMed Web of Science ®Google Scholar
• Ott PA, Hu Z, Keskin DB, Shukla SA, Sun J, Bozym DJ, Zhang W, Luoma A, Giobbie-Hurder A, Peter L, et al. An immunogenic personal neoantigen vaccine for patients with melanoma. Nature. 2017;547(7662):217–21. doi:10.1038/nature22991.
   PubMed Web of Science ®Google Scholar
• Tran E, Robbins PF, Lu YC, Prickett TD, Gartner JJ, Jia L, Pasetto A, Zheng Z, Ray S, Groh EM, et al. T-Cell transfer therapy targeting mutant KRAS in Cancer. N Engl J Med. 2016;375(23):2255–62. doi:10.1056/NEJMoa1609279.
   PubMed Web of Science ®Google Scholar
• Wu Y, Wan T, Zhou X, Wang B, Yang F, Li N, Chen G, Dai S, Liu S, Zhang M, et al. Hsp70-like protein 1 fusion protein enhances induction of carcinoembryonic antigen-specific CD8+ CTL response by dendritic cell vaccine. Cancer Res. 2005;65(11):4947–54. doi:10.1158/0008-5472.can-04-3912.
   PubMed Web of Science ®Google Scholar
• Gnirke A, Melnikov A, Maguire J, Rogov P, LeProust EM, Brockman W, Fennell T, Giannoukos G, Fisher S, Russ C, et al. Solution hybrid selection with ultra-long oligonucleotides for massively parallel targeted sequencing. Nat Biotechnol. 2009;27(2):182–89. doi:10.1038/nbt.1523.
   PubMed Web of Science ®Google Scholar
• Li H, Durbin R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics. 2009;25(14):1754–60. doi:10.1093/bioinformatics/btp324.
   PubMed Web of Science ®Google Scholar
• Ghosh S, Chan CK. Analysis of RNA-seq data using tophat and cufflinks. Methods Mol Biol. 2016;1374:339–61. doi:10.1007/978-1-4939-3167-5_18.
   PubMedGoogle Scholar
• Chen F, Zou Z, Du J, Su S, Shao J, Meng F, Yang J, Xu Q, Ding N, Yang Y, et al. Neoantigen identification strategies enable personalized immunotherapy in refractory solid tumors. J Clin Invest. 2019;129(5):2056–70. doi:10.1172/jci99538.
   PubMed Web of Science ®Google Scholar
• Szolek A, Schubert B, Mohr C, Sturm M, Feldhahn M, Kohlbacher O. OptiType: precision HLA typing from next-generation sequencing data. Bioinformatics. 2014;30(23):3310–16. doi:10.1093/bioinformatics/btu548.
   PubMed Web of Science ®Google Scholar
• Weese D, Holtgrewe M, Reinert K, Razer S. 3: faster, fully sensitive read mapping. Bioinformatics. 2012;28(20):2592–99. doi:10.1093/bioinformatics/bts505.
   PubMed Web of Science ®Google Scholar
• Bjerregaard AM, Nielsen M, Hadrup SR, Szallasi Z, Eklund AC. MuPeXI: prediction of neo-epitopes from tumor sequencing data. Cancer Immunol Immunother. 2017;66(9):1123–30. doi:10.1007/s00262-017-2001-3.
   PubMed Web of Science ®Google Scholar
• Kim B, Won D, Jang M, Kim H, Choi JR, Kim TI, Lee ST. Next-generation sequencing with comprehensive bioinformatics analysis facilitates somatic mosaic APC gene mutation detection in patients with familial adenomatous polyposis. BMC Med Genomics. 2019;12(1):103. doi:10.1186/s12920-019-0553-0.
   PubMedGoogle Scholar
• Tran E, Turcotte S, Gros A, Robbins PF, Lu YC, Dudley ME, Wunderlich JR, Somerville RP, Hogan K, Hinrichs CS, et al. Cancer immunotherapy based on mutation-specific CD4+ T cells in a patient with epithelial cancer. Science. 2014;344(6184):641–45. doi:10.1126/science.1251102.
   PubMed Web of Science ®Google Scholar
• He JD, Luo HL, Li J, Feng WT, Chen LB. Influences of the interferon induced transmembrane protein 1 on the proliferation, invasion, and metastasis of the colorectal cancer SW480 cell lines. Chin Med J (Engl). 2012;125:517–22.
   PubMed Web of Science ®Google Scholar
• Ogura M, Kakuda T, Takarada T, Nakamichi N, Fukumori R, Kim YH, Hinoi E, Yoneda Y. Promotion of both proliferation and neuronal differentiation in pluripotent P19 cells with stable overexpression of the glutamine transporter slc38a1. PLoS One. 2012;7(10):e48270. doi:10.1371/journal.pone.0048270.
   PubMed Web of Science ®Google Scholar
• Liu S, Yu Y, Zhang M, Wang W, Cao X. The involvement of TNF-alpha-related apoptosis-inducing ligand in the enhanced cytotoxicity of IFN-beta-stimulated human dendritic cells to tumor cells. J Immunol. 2001;166:5407–15. doi:10.4049/jimmunol.166.9.5407.
   PubMed Web of Science ®Google Scholar
• Sun W, Wei X, Niu A, Ma X, Li JJ, Gao D. Enhanced anti-colon cancer immune responses with modified eEF2-derived peptides. Cancer Lett. 2015;369:112–23. doi:10.1016/j.canlet.
   PubMed Web of Science ®Google Scholar
• Kilkenny C, Browne WJ, Cuthill IC, Emerson M, Altman DG. Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. Osteoarthritis Cartilage. 2012;20:256–60. doi:10.1016/j.joca.2012.02.010.
   PubMed Web of Science ®Google Scholar
• Slater AM, Cao LA. Protocol for housing mice in an enriched environment. J Visualized Exp. 2015;(100)e52874. doi:10.3791/52874.
   PubMed Web of Science ®Google Scholar
• Liu S, Yi L, Ling M, Jiang J, Song L, Liu J, Cao X. HSP70L1-mediated intracellular priming of dendritic cell vaccination induces more potent CTL response against cancer. Cell Mol Immunol. 2018;15(2):135–45. doi:10.1038/cmi.2016.33.
   PubMed Web of Science ®Google Scholar
• Su S, Hu B, Shao J, Shen B, Du J, Du Y, Zhou J, Yu L, Zhang L, Chen F, et al. CRISPR-Cas9 mediated efficient PD-1 disruption on human primary T cells from cancer patients. Sci Rep. 2016;6:20070. doi:10.1038/srep20070.
   PubMed Web of Science ®Google Scholar
• Liu C, Zheng Y, Tang J, Wang D, Ma Z, Li S, Chang X. Stimulation of DC-CIK with PADI4 protein can significantly elevate the therapeutic efficiency in esophageal cancer. J Immunol Res. 2019;2019:6587570. doi:10.1155/2019/6587570.
   PubMed Web of Science ®Google Scholar
• Zacharakis N, Chinnasamy H, Black M, Xu H, Lu YC, Zheng Z, Pasetto A, Langhan M, Shelton T, Prickett T, et al. Immune recognition of somatic mutations leading to complete durable regression in metastatic breast cancer. Nat Med. 2018;24(6):724–30. doi:10.1038/s41591-018-0040-8.
   PubMed Web of Science ®Google Scholar
• Jinushi M, Hodi FS, Dranoff G. Enhancing the clinical activity of granulocyte-macrophage colony-stimulating factor-secreting tumor cell vaccines. Immunol Rev. 2008;222:287–98. doi:10.1111/j.1600-065X.2008.00618.x.
   PubMed Web of Science ®Google Scholar
• Bjerregaard AM, Nielsen M, Jurtz V, Barra CM, Hadrup SR, Szallasi Z, Eklund AC. An analysis of natural T cell responses to predicted tumor neoepitopes. Front Immunol. 2017;8:1566. doi:10.3389/fimmu.2017.01566.
   PubMed Web of Science ®Google Scholar
• Chen C, Liu S, Qu R, Li B. Recurrent neoantigens in colorectal cancer as potential immunotherapy targets. Biomed Res Int. 2020;2020:2861240. doi:10.1155/2020/2861240.
   PubMed Web of Science ®Google Scholar
• van den Bulk J, Verdegaal EME, Ruano D, Ijsselsteijn ME, Visser M, van der Breggen R, Duhen T, van der Ploeg M, de Vries NL, Oosting J, et al. Neoantigen-specific immunity in low mutation burden colorectal cancers of the consensus molecular subtype 4. Genome Med. 2019;11:87. doi:10.1186/s13073-019-0697-8.
   PubMed Web of Science ®Google Scholar
• Parkhurst MR, Robbins PF, Tran E, Prickett TD, Gartner JJ, Jia L, Ivey G, Li YF, El-Gamil M, Lalani A, et al. Unique neoantigens arise from somatic mutations in patients with gastrointestinal cancers. Cancer Discov. 2019;9:1022–35. doi:10.1158/2159-8290.
   PubMed Web of Science ®Google Scholar